Extensive Urticarial Vasculitis Lesions in a Post-COVID Patient: A Clinical Image Report
DOI:
https://doi.org/10.60591/crspmi.58Keywords:
COVID-19/complications, SARS-CoV-2, Urticaria, Vasculitis, Leukocytoclastic, CutaneousAbstract
.
Downloads
References
Rajan M B, Kumar-M P, Bhardwaj A. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review. Int J Dermatol. 2020;59:1358-70. doi: 10.1111/ijd.15154.
Seque CA, Enokihara M, Porro AM, Tomimori J. Skin manifestations associated with COVID-19. An Bras Dermatol. 2022;97:75-88. doi: 10.1016/j.abd.2021.08.002.
Fernández-Lázaro D, Garrosa M. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. Viruses. 2021;13. doi: 10.3390/v13101916.
Nasiri S, Dadkhahfar S, Abasifar H, Mortazavi N, Gheisari M. Urticarial vasculitis in a COVID-19 recovered patient. Int J Dermatol. 2020;59:1285-6. doi: 10.1111/ijd.15112.
de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, et al. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? J Eur Acad Dermatol Venereol. 2020;34:e566-e8. doi: 10.1111/jdv.16713.
Gu SL, Jorizzo JL. Urticarial vasculitis. Int J Womens Dermatol. 2021;7:290-7. doi: 10.1016/j.ijwd.2021.01.021.
